Liberty All-Star Growth Fund, Inc. (ASG)
Live price chart, market sentiment, and community perspectives for Liberty All-Star Growth Fund, Inc. (NYSE: ASG).
Live price chart, market sentiment, and community perspectives for Liberty All-Star Growth Fund, Inc. (NYSE: ASG).
On our desk, the valuation narrative for ASG looks seductive on paper given the 11% discount to NAV and the bumped $0.12 quarterly dividend yielding around 9.3%. However, looking closely at the multi-manager structure, it's clear the fund is forced to liquidate top-performing large caps just to feed that distribution policy. That's a structural treadmill that destroys long-term capital appreciation. Until we see improved execution from the sub-advisers or a meaningful narrowing of the NAV discount, clients are better off avoiding new capital allocation here.
From a risk management standpoint, the fundamental metrics flashing across our terminals for ASG are deeply concerning. An operating margin of -125.62% combined with an -80.60% YoY earnings drop and a Piotroski F-Score of 4 out of 9 signals severe underlying operational weakness. Even though the fund carries zero leverage debt/equity, the reliance on realized gains to support an unsustainably high yield leaves it dangerously exposed to any broad growth equity drawdown.
When evaluating closed-end growth vehicles like ASG for institutional portfolios, you have to look past the headline yield. Technical momentum has been erratic, with the fund dipping below its 200-day moving average before attempting a recovery past its 50-day moving average around $5.32. My protocol here is to treat any bounce as a tactical trading opportunity rather than a buy-and-hold income play, keeping a tight stop-loss below recent 52-week lows of $4.01.
Our quantitative screen flags ASG as a high-risk closed-end fund. The zero debt-to-equity ratio is a positive metric for leverage safety, but the fundamental health score (4/9) and severe earnings compression negate that benefit. If you are going to hold it for the managed distribution, expect high volatility and potential NAV decay as the multi-manager all-cap strategy struggles to outperform in choppy market conditions.
Watching retail sentiment on the message boards, there is a clear disconnect. Small investors are mesmerized by the 9.3% yield and the discounted entry relative to book value (P/B of 0.90). But fundamental analysts understand that this yield is not backed by healthy earnings or income-enhancing strategies. Without structural changes to how ASG generates distributable cash flow, the fund will likely continue lagging peers like STK.
Explore plasma cleansing, somatic organ swaps, and BCI.